GIP Receptor Activation (The Secret Sauce) The glucose-dependent insulinotropic peptide (GIP) pathway was dormant in older therapies but crucial for retatrutide's superiority: Metabolic Rate Increase : GIP activation increases energy expenditure by ~5-10% Fat Oxidation : Preferentially targets visceral and hepatic fat Muscle Preservation : Better maintains lean mass during weight loss Lipid Metabolism : Improves triglycerides and cholesterol profiles This is where retatrutide differs fundamentally from tirzepatide
Food and Drug Administration approved Foundayo (orforglipron), developed by Eli Lilly and Company, for chronic weight management
Here, well discuss strategies to avoid itching, including pre-medication steps, lifestyle changes, and early detection methods
Promotes tissue repair, provides antioxidant activity, and supports gut health
In the SURMOUNT trials evaluating tirzepatide specifically for weight management in people with obesity, participants achieved even greater weight reductions, with average losses of 1522% of initial body weight at the highest doses over 72 weeks